This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan CIAPIN1 paraffin-section IHC around cytoplasmic staining that can include nuclear signal (HPA tissue IHC). This guide highlights high staining in testis pachytene spermatocytes (HPA tissue IHC) and the catalog antibody’s 1:50–1:200 IHC dilution range (datasheet).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Cytoplasmic staining, sometimes with nuclear staining (HPA tissue IHC) | |
| Staining pattern | High in testis pachytene spermatocytes; mainly cytoplasmic (HPA tissue IHC) | |
| Antigen retrieval | Tris-EDTA pH 9.0 HIER, 95–98 °C, 20 min (rule: nuclear antigen) | |
| Positive control | Testis+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
| Fixation | Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image A04333) | |
| Caveat | Marrow hematopoietic cells may be unstained (HPA tissue IHC) | |
| Regulation | Cell-type staining levels vary across tissues (HPA tissue IHC) | |
| Isoform / epitope | 3 isoforms; check epitope coverage across variants (UniProt) |
The catalog antibody’s IHC-P protocol is accompanied by four published CIAPIN1 tissue IHC protocols (PMC6481027; PMC9267148; PMC3502349; PMC2516489).
| Sample | Paraffin-embedded human liver injury tissue; fixative not specified (datasheet A04333) |
| Fixation | Image fixative and duration unreported (datasheet A04333); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat-induced epitope retrieval in Tris-EDTA buffer, pH 9.0, 20 min at 95–98 °C (standard rule: nuclear antigen) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% normal serum of the secondary host, 30 min, room temperature (standard) |
| Primary antibody | Rabbit anti-CIAPIN1, 1:50-1:200 (datasheet A04333) |
| Primary incubation | Overnight at 4 °C (standard) |
| Detection | HRP-polymer secondary, DAB chromogen 5–10 min (standard) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | CIAPIN1-positive staining in pachytene spermatocytes of testis (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression in most tissues which in some tissues was combined with nuclear expression, most abundant in testis. No signal in the no-primary control. |
CIAPIN1 staining should be mainly cytoplasmic in tissue IHC, with nuclear staining in some tissues (HPA tissue IHC). Expect the strongest reported signal in testicular pachytene spermatocytes and medium signal in several glandular cell populations (HPA tissue IHC). UniProt also lists cytoplasmic, nuclear and mitochondrial intermembrane space locations; CIAPIN1 has no transmembrane segment (UniProt Q6FI81). HPA rates tissue IHC reliability Enhanced, with medium consistency between staining and RNA expression (HPA tissue IHC).
| Cytoplasmic staining in pachytene spermatocytes, with some nuclear signal. | This fits the high testis signal and the possibility of combined cytoplasmic and nuclear staining (HPA tissue IHC). Score the identified cells and compartments separately; a positive testis section is a useful comparison when judging a weak sample (general IHC practice). |
| Moderate cytoplasmic staining in appendix, duodenum, gallbladder, rectum, small intestine or stomach glandular cells, or ovarian follicle cells. | These cell populations have medium reported staining (HPA tissue IHC). Compare cells within the same section before calling a tissue globally positive; HPA reports cell specific observations, and staining intensity need not be uniform across a section (HPA tissue IHC; general IHC practice). |
| Predominantly cell surface, extracellular or acellular deposits instead of cellular cytoplasmic staining. | That distribution is discordant with reported tissue IHC and the absence of a transmembrane segment (HPA tissue IHC; UniProt Q6FI81 topology). Treat it as a possible artefact and review morphology and controls before assigning CIAPIN1 positivity (general IHC practice). |
| Strong signal in a cell population reported as not detected, or broad staining outside identifiable cells. | For example, HPA reports adipocytes and bone marrow hematopoietic cells as not detected (HPA tissue IHC). Investigate antibody cross-reactivity, endogenous detection activity or nonspecific background (general IHC practice). “Not detected” is an observed IHC result, not proof that expression is biologically absent (HPA tissue IHC). |
| No staining in testicular pachytene spermatocytes while the sample and counterstain remain interpretable. | This conflicts with HPA’s high staining in those cells (HPA tissue IHC). Check section quality, antigen retrieval, antibody and detection performance using appropriate controls (general IHC practice). One failed positive section does not establish that the study samples lack CIAPIN1 (general IHC practice). |
| Tissue and cell selection | HPA reports high staining in testicular pachytene spermatocytes, medium staining in several glandular populations, and low staining in pancreatic exocrine glandular cells (HPA tissue IHC). Choose comparison cells by their reported IHC level; UniProt’s high pancreatic tissue expression does not specify an IHC intensity for every pancreatic cell (UniProt Q6FI81; HPA tissue IHC). |
| Compartment and resolution | HPA tissue IHC is mainly cytoplasmic and sometimes nuclear; UniProt also lists the mitochondrial intermembrane space (HPA tissue IHC; UniProt Q6FI81). A chromogenic cytoplasmic result need not resolve individual mitochondria (general IHC practice). The absence of a transmembrane segment gives no basis for requiring membrane staining (UniProt Q6FI81 topology). |
| Isoforms and modified residues | UniProt lists three isoforms and several phosphorylated residues (UniProt Q6FI81). The supplied sources do not map the IHC antibodies’ epitopes, so these annotations cannot predict which isoform is detected or whether phosphorylation changes staining. Interpret an unexpected pattern against tissue controls rather than assigning it to an isoform or modification (general IHC practice). |
| Evidence and antibody agreement | HPA labels tissue IHC Enhanced and reports medium consistency with RNA data; both listed antibodies have Enhanced IHC validation (HPA tissue IHC; HPA antibodies). This supports the reported pattern without making every stained structure specific. Inspect control sections when a result conflicts with the expected cell type or compartment (general IHC practice). |
| IF/ICC Q&A: Must mitochondrial puncta appear in chromogenic IHC? | No. HPA’s ICC-IF summary reports supported mitochondrial localisation with additional nucleoplasmic localisation, while its tissue IHC profile describes mainly cytoplasmic staining, sometimes with nuclear staining (HPA subcellular ICC-IF; HPA tissue IHC). Judge the IHC section against its tissue IHC pattern. |
| Situation | Likely cause | Next action |
|---|---|---|
| The testis positive comparison is blank. | The result conflicts with high staining reported in pachytene spermatocytes; section or assay performance may be responsible (HPA tissue IHC; general IHC practice). | Confirm the target cells are present, then review retrieval, antibody incubation, chromogenic detection and control performance before interpreting study sections (general IHC practice). |
| All cells show a diffuse brown haze. | Nonspecific staining or endogenous detection activity can obscure cellular localisation (general IHC practice). | Inspect a no-primary control, review blocking and washing, and adjust the staining workflow until identifiable cellular signal can be distinguished from background (general IHC practice). |
| Only nuclei stain strongly across a tissue section. | Some nuclear signal is compatible with HPA, but a uniformly nuclear-only pattern differs from its mainly cytoplasmic tissue profile (HPA tissue IHC). | Compare with cytoplasmic staining in an appropriate positive section and review background and antibody controls before scoring the nuclei as specific (HPA tissue IHC; general IHC practice). |
| Adipocytes or bone marrow hematopoietic cells appear strongly positive. | HPA reports these cell populations as not detected by tissue IHC, making strong staining discordant with its observations (HPA tissue IHC). | Check cell identification and a no-primary control; assess cross-reactivity or endogenous detection activity before interpreting the signal as CIAPIN1 (general IHC practice). |
| Pancreatic exocrine glandular cells stain weakly. | HPA reports low IHC staining in these cells, although UniProt describes high expression in pancreas at the tissue level (HPA tissue IHC; UniProt Q6FI81). | Use the cell specific IHC observation when judging the section; compare a known stronger IHC population if assay sensitivity remains uncertain (HPA tissue IHC; general IHC practice). |
| Signal pools at section edges or outside cells. | Edge or acellular deposits do not match the cellular cytoplasmic IHC profile (HPA tissue IHC; general IHC practice). | Review section morphology, washing and chromogen development, then score only interpretable cellular staining alongside appropriate controls (general IHC practice). |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | Pachytene spermatocytes | High | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Medium | Protein (IHC) | HPA → |
| Duodenum | Glandular cells | Medium | Protein (IHC) | HPA → |
| Gallbladder | Glandular cells | Medium | Protein (IHC) | HPA → |
| Ovary | Follicle cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | Glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebellum | Cells in granular layer | Not detected | Protein (IHC) | HPA → |
Troubleshoot CIAPIN1 staining by checking retrieval, compartment, controls and cell-specific scoring before interpreting signal intensity.
A04333 is listed for human and mouse IHC and IF (catalog: applications, reactivity). Its IHC figure shows a paraffin-embedded human liver injury specimen (A04333 image caption); no IF figure is supplied (catalog: IF image alts).
A04333 lists IHC and IF applications and human and mouse reactivity (catalog: applications, reactivity). Its IHC figure depicts paraffin-embedded human liver injury (A04333 image caption); the catalog supplies no IF figure (catalog: IF image alts).
Which to pick: For tissue IHC, choose A04333: its own figure shows a paraffin-embedded human liver injury specimen, but the fixative is unreported (A04333 image caption). For IF/ICC, A04333 lists IF at 1:50–1:200; no IF figure or ICC validation is supplied (catalog: applications, IF dilution, IF image alts). For cross-species work, A04333 lists human and mouse reactivity and a rabbit host; clonality is unreported (catalog: reactivity, host, clone).